A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)
NCT06213038
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Neovascular Age-related Macular Degeneration
Interventions
GENETIC:
SKG0106
Sponsor
Youxin Chen